First Light Biosciences, Inc.
First Light Biosciences is a development stage company creating novel medical diagnostic products for preventing and detecting healthcare associated infections. The company's MultiPath technology, which uses digital imaging to count cells and molecules without magnification, enables sensitivities comparable to DNA-based diagnostics but with improved cost-effectiveness, ease-of-use, and automation. The company aims to be the first to enable any hospital to afford to use rapid screening to prevent hospital infections caused by bacterial agents such as MRSA. The company's products can be used to detect a broad range of infectious disease targets, including antibiotic resistant bacteria, toxins, viruses, and biomarkers.Back to list